Paraventricular nucleus regulatory mechanisms in stress and hypertension

应激和高血压的室旁核调节机制

基本信息

  • 批准号:
    7903187
  • 负责人:
  • 金额:
    $ 40.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-08-01 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): It is established that the central nervous system (CNS) contributes to the long-term regulation of blood pressure in both health and disease via effects on neuroendocrine mechanisms and sympathetic outflow. Specifically, elevations in baseline and stress-induced activation of the hypothalamic-pituitary-adrenal (HPA) axis activity and sympathetic nervous system function are implicated in the etiology of hypertension in humans and in related animal models including the spontaneously hypertensive rat (SHR). However, CNS mechanisms that mediate chronic increases in baseline blood pressure and/or stress reactivity are inadequately understood. The overall goal of our research program is to elucidate mechanisms within the brain that mediate chronic changes in baseline and stress-activated blood pressure regulation. The experiments in this application focus on regulatory mechanisms within the paraventricular nucleus (PVN) of the hypothalamus. Neurons within the PVN are critical to the central regulation of both the HPA axis and the sympathetic nervous system, and angiotensin II (Ang II) acting within the PVN has emerged as one key neuropeptide that can activate both of these outputs. We have recently identified macrophage migration inhibitory factor (MIF) as an intracellular negative regulator of the excitatory actions of Ang II in normotensive rat neurons. Collectively, our studies indicate that MIF acts within PVN neurons of normotensive rats via its intrinsic thiol protein oxidoreductase (TPOR) activity to attenuate the cardiovascular actions of Ang II. However, our data indicate this regulatory mechanism is absent from PVN neurons of SHR, and that long-term replacement of MIF within SHR neurons blunts the age-related increase in baseline blood pressure observed in this model of hypertension. These results establish an important role for MIF in attenuating the excitatory effects of Ang II, acting within the PVN, to promote age-related increases in baseline blood pressure. The present application specifically investigates the role of PVN MIF in the modulation of Ang II-mediated blood pressure regulation during acute and chronic stress, and potential contributions of both the HPA axis and the sympathetic nervous system to blood pressure regulation will be determined. The overall hypothesis is that replacement of MIF within PVN neurons of SHR will attenuate the increased blood pressure reactivity to stress observed in these animals by a mechanism that requires the TPOR activity of MIF. The specific goal is to test this hypothesis by utilizing AAV2-mediated gene delivery to chronically express MIF, or a mutant MIF protein that lacks TPOR activity, selectively in PVN neurons of SHR and normotensive control rats. This goal will be achieved via the following Specific Aims: Aim 1 is to determine the effects of long-term viral-mediated expression of MIF within PVN neurons of SHR and normotensive rats on blood pressure regulation during acute and chronic stress. Aim 2 is to determine the role of the TPOR moiety of MIF in mediating the effects of MIF within PVN neurons of SHR and normotensive rats on blood pressure regulation during acute and chronic stress. PUBLIC HEALTH RELEVANCE: Current treatment of high blood pressure primarily targets symptoms rather than causes or prevention because the causes of high blood pressure are not established. It is now understood that people who have a high level of stress in their lives and/or react excessively to stress have an increased risk for high blood pressure. The goal of the proposed studies is to show that macrophage migration inhibitory factor in the brain is a key regulator of blood pressure at rest and during stress, thus providing a novel target for the prevention and treatment of high blood pressure.
描述(由申请人提供):确定中枢神经系统(CNS)通过对神经内分泌机制和交感神经流出的影响来促进健康和疾病中血压的长期调节。具体而言,基线和应力诱导的下丘脑 - 垂体 - 肾上腺(HPA)轴活动和交感神经系统功能的激活与人类和相关动物模型的高血压病因有关,包括自发性高度高性大鼠(SHR)。但是,介导基线血压和/或应激反应性慢性增加的中枢神经系统机制是不充分理解的。我们的研究计划的总体目标是阐明大脑内的机制,以介导基线和压力激活的血压调节的慢性变化。该应用中的实验集中于下丘脑室室核(PVN)内的调节机制。 PVN中的神经元对于HPA轴和交感神经系统的中心调节至关重要,而在PVN中作用的血管紧张素II(ANG II)已成为一种可以激活这两个输出的关键神经肽。我们最近将巨噬细胞迁移抑制因子(MIF)确定为正常大鼠神经元中ANG II兴奋性作用的细胞内负调节剂。总的来说,我们的研究表明,MIF通过其内在的硫醇蛋白氧化还原酶(TPOR)活性在正常大鼠的PVN神经元内作用,以减轻ANG II的心血管作用。但是,我们的数据表明,SHR的PVN神经元没有这种调节机制,而SHR神经元内MIF的长期替代使这种高血压模型中观察到的基线血压的增加相关。这些结果确定了MIF在衰减PVN内的ANG II的兴奋作用方面的重要作用,以促进基线血压与年龄相关的增加。本应用专门研究了PVN MIF在急性和慢性应激过程中ANG II介导的血压调节调节调节中的作用,以及HPA轴和交感神经系统对血压调节的潜在贡献。总体假设是,在SHR的PVN神经元内替换MIF将通过需要MIF的TPOR活性的机制来减轻这些动物中观察到的压力的血压反应性的增加。具体的目标是通过利用AAV2介导的基因递送到慢性表达MIF或缺乏TPOR活性的突变型MIF蛋白,在SHR和正常对照大鼠的PVN神经元中选择性地检验该假设。该目标将通过以下特定目的实现:目标1是确定MIF在SHR和正常大鼠PVN神经元中长期病毒介导的表达对急性和慢性应激期间血压调节的影响。目的2是确定MIF的Tpor部分在SHR和正常大鼠PVN神经元中介导MIF在急性和慢性应激期间血压调节的作用。公共卫生相关性:当前高血压治疗主要针对症状,而不是原因或预防,因为没有建立高血压的原因。现在可以理解,生活中压力很高和/或对压力过度反应的人会增加高血压的风险。拟议的研究的目的是表明大脑中的巨噬细胞迁移抑制因子是静止和压力期间血压的关键调节剂,因此为预防和治疗高血压提供了新的目标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

COLIN SUMNERS其他文献

COLIN SUMNERS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('COLIN SUMNERS', 18)}}的其他基金

Angiotensin-sensitive neurons in the nucleus of the solitary tract mediate social stress induced hypertension
孤束核中血管紧张素敏感神经元介导社会压力诱发的高血压
  • 批准号:
    10668569
  • 财政年份:
    2017
  • 资助金额:
    $ 40.86万
  • 项目类别:
Paraventricular nucleus regulatory mechanisms in stress and hypertension
应激和高血压的室旁核调节机制
  • 批准号:
    8293201
  • 财政年份:
    2009
  • 资助金额:
    $ 40.86万
  • 项目类别:
Paraventricular nucleus regulatory mechanisms in stress and hypertension
应激和高血压的室旁核调节机制
  • 批准号:
    8116642
  • 财政年份:
    2009
  • 资助金额:
    $ 40.86万
  • 项目类别:
Paraventricular nucleus regulatory mechanisms in stress and hypertension
应激和高血压的室旁核调节机制
  • 批准号:
    7729905
  • 财政年份:
    2009
  • 资助金额:
    $ 40.86万
  • 项目类别:
Paraventricular nucleus regulatory mechanisms in stress and hypertension
应激和高血压的室旁核调节机制
  • 批准号:
    8476247
  • 财政年份:
    2009
  • 资助金额:
    $ 40.86万
  • 项目类别:
MIF: A novel CNS regulator of cardiovascular function
MIF:心血管功能的新型中枢神经系统调节剂
  • 批准号:
    7102601
  • 财政年份:
    2005
  • 资助金额:
    $ 40.86万
  • 项目类别:
MIF: A novel CNS regulator of cardiovascular function
MIF:心血管功能的新型中枢神经系统调节剂
  • 批准号:
    8447494
  • 财政年份:
    2005
  • 资助金额:
    $ 40.86万
  • 项目类别:
MIF: A novel CNS regulator of cardiovascular function
MIF:心血管功能的新型中枢神经系统调节剂
  • 批准号:
    7239526
  • 财政年份:
    2005
  • 资助金额:
    $ 40.86万
  • 项目类别:
MIF: A novel CNS regulator of cardiovascular function
MIF:心血管功能的新型中枢神经系统调节剂
  • 批准号:
    8105814
  • 财政年份:
    2005
  • 资助金额:
    $ 40.86万
  • 项目类别:
MIF: A novel CNS regulator of cardiovascular function
MIF:心血管功能的新型中枢神经系统调节剂
  • 批准号:
    8261078
  • 财政年份:
    2005
  • 资助金额:
    $ 40.86万
  • 项目类别:

相似国自然基金

小细胞肺癌脑、肾上腺等多器官转移的谱系可塑性机制与干预研究
  • 批准号:
    82330087
  • 批准年份:
    2023
  • 资助金额:
    220 万元
  • 项目类别:
    重点项目
STAT5促进肾上腺素生成介导髓系造血及肿瘤免疫抑制的机制研究
  • 批准号:
    82372908
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
慢性压力刺激调控释放的肾上腺素影响TAMs极化促进结肠癌进展的机制研究
  • 批准号:
    82303327
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
内皮β3肾上腺素能受体调控线粒体功能参与血管衰老的作用研究
  • 批准号:
    82370408
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
SARS-CoV-2刺突蛋白作为β肾上腺素受体配体介导心脏炎症和纤维化的机制研究
  • 批准号:
    82300295
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Stress-induced cardiovascular dysfunction in dilated cardiomyopathy
扩张型心肌病中应激诱发的心血管功能障碍
  • 批准号:
    10604281
  • 财政年份:
    2020
  • 资助金额:
    $ 40.86万
  • 项目类别:
Stress-induced cardiovascular dysfunction in dilated cardiomyopathy
扩张型心肌病中应激诱发的心血管功能障碍
  • 批准号:
    10370369
  • 财政年份:
    2020
  • 资助金额:
    $ 40.86万
  • 项目类别:
Adrenal cell ATP1A1 mutations and mechanisms of aldosterone biosynthesis
肾上腺细胞ATP1A1突变与醛固酮生物合成机制
  • 批准号:
    9981536
  • 财政年份:
    2019
  • 资助金额:
    $ 40.86万
  • 项目类别:
Adrenal Mineralocorticoid Receptor Activity Regulates Aldosterone and Cortisol Production
肾上腺盐皮质激素受体活性调节醛固酮和皮质醇的产生
  • 批准号:
    10264775
  • 财政年份:
    2019
  • 资助金额:
    $ 40.86万
  • 项目类别:
Adrenal cell ATP1A1 mutations and mechanisms of aldosterone biosynthesis
肾上腺细胞ATP1A1突变与醛固酮生物合成机制
  • 批准号:
    10447775
  • 财政年份:
    2019
  • 资助金额:
    $ 40.86万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了